The American Diabetes Association’s Scientific Sessions always produce a flood of obesity and diabetes news. Every year brings new data, new molecules, and new promises about what the future of treatment might look like. This year was no different. Yet when the dust settled in New Orleans, one drug seemed to dominate nearly every conversation among pati…